Efficacy and safety of induction therapy with rabbit antithymocyte globulins in liver transplantation for hepatitis C

Transplantation Proceedings

Volumn 36, Issue 9, 2004, Pages 2757-2761

  Kamar, N ^a   Ribes, D ^a   Sandres Saune, K ^b   Suc, B ^a   Barange, K ^b   Cointault, O ^a   Lavayssiere, L ^a   Durand, D ^a   Izopet, J ^b   Rostaing, L ^a  

^a CHU RANGUEIL   (France)

^b CHU PURPAN   (France)

Author keywords

[No Author keywords available]

Indexed keywords

CD2 ANTIGEN; INSULIN; RABBIT ANTISERUM; RABBIT ANTITHYMOCYTE GLOBULIN; STEROID; TACROLIMUS; THYMOCYTE ANTIBODY; THYMOGLOBULINS; UNCLASSIFIED DRUG; VIRUS RNA;

ACUTE GRAFT REJECTION; ADULT; ARTICLE; BACTERIAL INFECTION; BIOCHEMISTRY; CLINICAL ARTICLE; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; CYTOMEGALOVIRUS INFECTION; DIABETES MELLITUS; DOSE RESPONSE; DRUG EFFICACY; DRUG SAFETY; END STAGE LIVER DISEASE; FEMALE; GRAFT REJECTION; HEPATITIS C; HEPATITIS C VIRUS; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; INCIDENCE; LIVER DISEASE; LIVER GRAFT; LIVER TRANSPLANTATION; MALE; MYCOSIS; POSTOPERATIVE PERIOD; PREOPERATIVE PERIOD; PRIORITY JOURNAL; RECURRENT DISEASE; SERUM SICKNESS; SURVIVAL RATE; VIROLOGY; VIRUS INFECTION;

ADULT; ALANINE TRANSAMINASE; ANIMALS; ANTILYMPHOCYTE SERUM; ASPARTATE AMINOTRANSFERASES; FEMALE; HEPATITIS C; HUMANS; IMMUNOSUPPRESSIVE AGENTS; LEUKOCYTE COUNT; LIVER FAILURE; LIVER TRANSPLANTATION; MALE; MIDDLE AGED; RABBITS; RETROSPECTIVE STUDIES; SAFETY; TACROLIMUS; TISSUE DONORS;

EID: 19944417233     PISSN: 00411345     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.transproceed.2004.10.003     Document Type: Article

References (21)

1. E. Gane The natural history and outcome of liver transplantation in hepatitis C virus-infected recipients Liver Transpl 9 2003 S28
2. Y. Calmus, J.R. Scheele, I. Gonzalez-Pinto Immunoprophylaxis with basiliximab, a chimeric anti-interleukin-2 receptor monoclonal antibody, in combination with azathioprine- containing triple therapy in liver transplant recipients Liver Transpl 8 2002 123
3. P. Neuhaus, P.A. Clavien, D. Kittur Improved treatment response with basiliximab immunoprophylaxis after liver transplantation: results from a double-blind randomized placebo-controlled trial Liver Transpl 8 2002 132
4. D.R. Nelson, C. Soldevila-Pico, A. Reed Anti-interleukin-2 receptor therapy in combination with mycophenolate mofetil is associated with more severe hepatitis C recurrence after liver transplantation Liver Transpl 7 2001 1064
5. H.R. Rosen, C.R. Shackleton, L. Higa Use of OKT3 is associated with early and severe recurrence of hepatitis C after liver transplantation Am J Gastroenterol 92 1997 1453
6. J.D. Eason, G.E. Loss, J. Blazek Steroid-free liver transplantation using rabbit antithymocyte globulin induction: results of a prospective randomized trial Liver Transpl 7 2001 693
7. M. Berenguer, M. Prieto, F. San Juan Contribution of donor age to the recent decrease in patient survival among HCV-infected liver transplant recipients Hepatology 36 2002 202
8. J.R. Lake The role of immunosuppression in recurrence of hepatitis C Liver Transpl 9 2003 S63
9. E.J. Gane, N.V. Naoumov, K.P. Qian A longitudinal analysis of hepatitis C virus replication following liver transplantation Gastroenterology 110 1996 167
10. Starzl TE: Immunosuppression in man. In: Starzl TE, Putman CW (eds): Experience in hepatic transplantation. Philadelphia: Saunders. 1969; p. 242
11. C. Cisneros Alonso, M.A. Diaz Castellanos, A. Montero Castillo [Antilymphocytic sera versus azathioprine, combined with cyclosporin and steroids, in liver transplant Comparison of the results at the intensive care unit and 2 years' follow-up] Rev Clin Esp 186 1990 68
12. J.M. Langrehr, J. Klupp, G. Junge Quadruple versus dual tacrolimus-based induction after liver transplantation: a prospective, randomized trial Transplant Proc 33 2001 2330
13. A. Rafecas, L. Llado, M.T. Albiol Immunosuppression with calcineurin inhibitors and polyclonal antibodies in liver transplantation Transplant Proc 34 2002 107
14. A.J. Tector, J.A. Fridell, R.S. Mangus Promising early results with immunosuppression using rabbit anti-thymocyte globulin and steroids with delayed introduction of tacrolimus in adult liver transplant recipients Liver Transpl 10 2004 404
15. W.J. Wall Use of antilymphocyte induction therapy in liver transplantation Liver Transpl Surg 5 suppl 1 1999 S64
16. L. Llado, J. Figueras, E. Ramos Prospective evaluation of a quadruple therapy based on tacrolimus after liver transplantation Transplant Proc 34 2002 108
17. J.D. Eason, S. Nair, A.J. Cohen Steroid-free liver transplantation using rabbit antithymocyte globulin and early tacrolimus monotherapy Transplantation 75 2003 1396
18. G. Missale, R. Bertoni, V. Lamonaca Different clinical behaviors of acute hepatitis C virus infection are associated with different vigor of the anti-viral cell-mediated immune response J. Clin Invest 98 1996 706
19. J.T. Gerlach, H.M. Diepolder, M.C. Jung Recurrence of hepatitis C virus after loss of virus-specific CD4(+) T-cell response in acute hepatitis C Gastroenterology 117 1999 933
20. D.R. Nelson, C.G. Marousis, G.L. Davis The role of hepatitis C virus-specific cytotoxic T lymphocytes in chronic hepatitis C J Immunol 158 1997 1473
21. H.R. Rosen, C. Miner, A.W. Sasaki Frequencies of HCV-specific effector CD4+ T cells by flow cytometry: correlation with clinical disease stages Hepatology 35 2002 190